Routine measurement of plasma calcitonin in nodular thyroid diseases

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1589-1593

  Vierhapper, H ^a   Raber, W ^b   Bieglmayer, C ^b   Kaserer, K ^b   Weinhausl A ^b   Niederle, B ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER RISK; CELL HYPERPLASIA; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MALIGNANT TRANSFORMATION; NODULAR GOITER; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT PLANNING;

EID: 0030950563     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.5.3949     Document Type: Article

References (16)

1. Mortensen JD, Woolner LJ, Bennet WA. 1955 Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab. 15:1270-1280.
2. Oertel JE, Klick GH. 1965 Structural changes in the thyroid glands of healthy young men. Med Ann District Columbia. 34:75-77.
3. Ridgway EC. 1992 Clinician's evaluation of a solitary thyroid nodule. J Clin Endocrinol Metab. 74:231-235.
4. Mazzaferri EL. 1992 Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med. 93:359-362.
5. Melvin KEW, Miller HH, Tashjian Jr AH. 1973 Early diagnosis of medullary carcinoma of the thyroid by means of calcitonin assay. N Engl J Med. 285:1115-1120.
6. Sheppard MC. 1995 Should serum calcitonin be measured routinely in all patients with nodular thyroid disease? Clin Endocrinol (Oxf). 42:451-452.
7. Pacini F, Fontanelli M, Fugazzola L, et al. 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab. 78:826-829.
8. Rieu M, Lame C-C, Richard A, et al. 1995 Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf). 42:453-460.
9. Fink M, Weinhäusel A, Niederle B, Haas OA. 1996 Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the ret proto-oncogene. Int J Cancer. 69:312-316.
10. Rosai J, Caracangiu ML, DeLellis RA. 1992 Atlas of tumor pathology: tumors of the thyroid gland, 3rd series. Washington DC: Armed Forcees Institute of Pathology; 247-258.
11. Barbot N, Calmettes C, Schuffenecker I, et al. 1994 Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab. 78:114-120.
12. Hedinger C, Williams ED, Sobin LH. 1988 Histological typing of thyroid tumors. In: World Health Organization international histological classification of tumors, 2nd ed. Berlin: Springer-Verlag.
13. Papotti M, Sambataro D, Pecchioni C, Bussolati G. 1996 The pathology of medullary carcinoma of the thyroid: review of the literature and personal experience on 62 cases. Endocr Pathol. 7:1-20.
14. Albores-Saavedra J, Monforte H, Nadji M, Morales AR. 1988 C-Cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol. 19:795-799.
15. Wolfe HJ, Melvin KEW, Cervi-Skinner SJ, et al. 1973 C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med. 289:437-441.
16. Längle F, Soliman T, Neuhold N, et al. 1974 CD15(LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? World J Surg. 18:583-587.